Method for dissociation of Cap protein in porcine circovirus II alumina gel adjuvant vaccine

Method for dissociation of Cap protein in porcine circovirus II alumina gel adjuvant vaccine

The invention provides a porcine circovirus II alumina gel adjuvant vaccine. A used dissociation agent has a nucleotide sequence shown in the formula of SEQ ID NO: 1. The provided dissociation agent can effectively dissociate a Cap protein antigen in the porcine circovirus II alumina gel adjuvant va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FAN GENCHENG, ZHANG HENG, DU YUANZHAO
Format: Patent
Sprache:eng
Schlagworte:
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TESTING
VINEGAR
WINE
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides a porcine circovirus II alumina gel adjuvant vaccine. A used dissociation agent has a nucleotide sequence shown in the formula of SEQ ID NO: 1. The provided dissociation agent can effectively dissociate a Cap protein antigen in the porcine circovirus II alumina gel adjuvant vaccine so that vaccine effects can be accurately and effectively evaluated. The method is a good method for alumina gel adjuvant vaccine effect detection. The method has the advantages of simple operation, low equipment requirement and large sample treatment amount.